Share
clock Created with Sketch.
17/04/15
22:48
Share
Originally posted by Stayso 54
↑
One of the things that is often said about champions is to never write them off. In other words whatever it is that gave them that reputation is always going to be present - it isn't going to abandon them easily. I made this similar remark I think last night or the night before and it put me in two minds as to whether I should follow conventional wisdom or not in relation to selling some NRT following another price surge.
I am now very glad I didn't.
Today we saw Novogen act in the manner of a 'champion'. There was an expectation of one thing and then it performed otherwise and so very easily could have closed on or above the 52 week high.
And I have to say that what we saw today was in my mind at least, some further evidence that this company and its seemingly unassuming but brilliant CEO have some real intentions to stick around for a very long time. Clearly, the old assumptions about Novogen should have been finally laid to rest today. Furthermore, all the warnings and dire predictions about Biotechs generally can NOT be dumped on this company because the FACT is that it has passed every test with first class honours. So called blue chip stocks do exist in the health care sector and I think people are starting to wake up that this is one in the making.
And the next step in the 'making ' of this champion is well and truly on show early next week with Professor Gil Mor in the saddle.
I think you might be right Robert. Correct weight at 50 cents.
Expand
Speaking about champions reminds me of of a phrase the wisest man I know (also the cookiest but mind you millionaire in the hundreds...) would repeat to me often.
He taught me the difference between a champion race horse and just 'any other' race horse is a few split seconds.
Rings true for NRT - this race horse is not just split seconds ahead of the rest of the pack. It's far greater.